Table 4.
Characteristics of the three pSS patients with previously identified autoimmune liver disease (AILD).
| Sex/year of birth | F‐1939 | F‐1957 | F‐1978 |
|---|---|---|---|
| Year of pSS diagnosis | 2002 | 2012 | 2012 |
| Year of sampling | 2014 | 2014 | 2014 |
| Year of AILD diagnosis | AIH (2013) | AIH (2017) | AIH (2017) |
| Liver biopsy | Yes | Yes | Yes |
| Liver enzymes | Hepatocellular | Normal | Cholestatic |
| SMA | − | (+) | − |
| M2/M4 | − | − | − |
| LKM | − | − | − |
| AMA‐M2 | − | − | − |
| 3E (BPO) | − | − | − |
| Sp100 | − | − | − |
| gp210 | − | − | − |
| SLA/LP | − | +++ | − |
| Ro52/SSA | +++ | +++ | +++ |
| IF‐ANA (pattern) | AC‐1+4 | AC‐1+8 | AC‐5 |
F = female; M = male; − = negative; +++ = strongly positive; (+) = weakly positive; pSS = primary Sjögren’s syndrome; AILD = autoimmune liver disease; SMA = smooth muscle antibodies; LKM = liver kidney microsomal antigen; AMA = anti‐mitochondrial antibodies; SLA/LP = soluble liver antigen/liver pancreas antigen; ANA = anti‐nuclear antibodies; AIH = autoimmune hepatitis.